Fanni Krajner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fanni Krajner has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Alessia Avila
University Clinic of Psychiatry and Medical Psychology, Faculty of Medicine, University of Lisbon, 1649-028 Lisbon, Portugal
1 shared publication - Alice Egerton
King's College London
1 shared publication - Amy Gillespie
Department of Psychiatry, University of Oxford, Oxford, UK
1 shared publication - David J. Lythgoe
Department of Neuroimaging, King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK
1 shared publication - Emily P. Hedges
Department of Psychosis Studies, Institute of Psychiatry , Psychology & Neuroscience, King's College London, London SE5 8AF
1 shared publication - Gareth J. Barker
Department of Neuroimaging, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
1 shared publication
Latest Publications
- Open Access
- 2 March 2022
- Published by Springer Nature in Schizophrenia
- Vol. 8 (1) , 1-8
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity.
- 2 March 2022
- Published by Springer Nature in Schizophrenia
- Vol. 8 (1) , 1-8
Open AccessSubcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophrenia
The neurobiological effects of clozapine are under characterised. We examined the effects clozapine treatment on subcortical volume and cortical thickness and investigated whether macrostructural changes were linked to alterations in glutamate or N-acetylaspartate (NAA). Data were acquired in 24 patients with treatment-resistant schizophrenia before and 12 weeks after switching to clozapine. During clozapine treatment we observed reductions in caudate and putamen volume, lateral ventricle enlargement (P < 0.001), and reductions in thickness of the left inferior temporal cortex, left caudal middle frontal cortex, and the right temporal pole. Reductions in right caudate volume were associated with local reductions in NAA (P = 0.002). None of the morphometric changes were associated with changes in glutamate levels. These results indicate that clozapine treatment is associated with subcortical volume loss and cortical thinning and that at least some of these effects are linked to changes in neuronal or metabolic integrity.